Story by Hadiyah Brendel | Uniformed Services University | 04.24.2025
The USU-developed monoclonal antibody 1F5 (MBP1F5) has been recognized by the Coalition for Epidemic Preparedness Innovations (CEPI) as a top innovation for 2024 due to its potential to protect against the deadly Nipah virus, driving forward clinical trials....
